173 related articles for article (PubMed ID: 34538672)
1. Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit.
Schlobohm CJ; Zhu E; Duby JJ
Burns; 2021 Nov; 47(7):1495-1501. PubMed ID: 34538672
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
Hong LT; Goolsby TA; Sherman DS; Mueller SW; Reynolds P; Cava L; Neumann R; Kiser TH
J Crit Care; 2015 Oct; 30(5):1153.e1-6. PubMed ID: 26239323
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
Bissell BD; Riggi G; Morrison C
J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744
[TBL] [Abstract][Full Text] [Related]
4. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
[TBL] [Abstract][Full Text] [Related]
5. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
[TBL] [Abstract][Full Text] [Related]
6. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.
Shakeraneh P; Fazili T; Wang D; Gilotra T; Steele JM; Seabury RW; Miller CD; Darko W; Probst LA; Kufel WD
Pharmacotherapy; 2020 Apr; 40(4):357-362. PubMed ID: 32090347
[TBL] [Abstract][Full Text] [Related]
8. [Continuous administration of vancomycin in patients with severe burns].
Conil JM; Favarel H; Laguerre J; Brouchet A; Chabanon G; Cazal L; Bodnar M; Rougé D; Virenque C; Costagliola M
Presse Med; 1994 Nov; 23(34):1554-8. PubMed ID: 7824489
[TBL] [Abstract][Full Text] [Related]
9. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intermittent versus continuous-infusion vancomycin for treating severe patients in intensive care units.
Yamada CH; Telles JP; Oliveira DDS; Cieslinski J; Ribeiro VST; Gasparetto J; Tuon FF
Braz J Infect Dis; 2020; 24(4):356-359. PubMed ID: 32763234
[TBL] [Abstract][Full Text] [Related]
11. Retrospective multicentre matched cohort study comparing safety and efficacy outcomes of intermittent-infusion versus continuous-infusion vancomycin.
Ma NH; Walker SAN; Elligsen M; Kiss A; Palmay L; Ho G; Powis J; Bansal V; Leis JA
J Antimicrob Chemother; 2020 Apr; 75(4):1038-1046. PubMed ID: 31919504
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
[TBL] [Abstract][Full Text] [Related]
13. [Continuous and intermittent infusion of vancomycin equally effective: review of the literature].
van Maarseveen EM; Man WH; Touw DJ; Bouma AW; van Zanten AR
Ned Tijdschr Geneeskd; 2011; 155(42):A2667. PubMed ID: 22027450
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.
Demirel B; İmamoglu E; Gursoy T; Demirel U; Topçuoglu S; Karatekin G; Ovali F
J Neonatal Perinatal Med; 2015; 8(2):149-55. PubMed ID: 26410440
[TBL] [Abstract][Full Text] [Related]
16. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
17. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
[TBL] [Abstract][Full Text] [Related]
18. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
19. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
Duszynska W; Taccone FS; Hurkacz M; Wiela-Hojenska A; Kübler A
Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702
[TBL] [Abstract][Full Text] [Related]
20. Review of continuous-infusion vancomycin.
DiMondi VP; Rafferty K
Ann Pharmacother; 2013 Feb; 47(2):219-27. PubMed ID: 23386074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]